Search results
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 5 days agoTremfya is presently approved to treat certain patients with plaque psoriasis and active psoriatic...
Change Eligibility Rules for More Diverse Clinical Trials?
Medscape· 5 days agoExpanding eligibility criteria is a strategy for improving the inclusion of traditionally...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 6 days agoBMS strengthened its neuroscience portfolio with the acquisition of Karuna Therapeutics, and its lead asset, KarXT (trospium chloride + xanomeline), a...
5 signs your skin is just as stressed out as you are
Fortune· 5 days agoAddressing your skin’s stress is a task that requires both inner work and outer work. Below, Camp and dermatologist Dr. Blair Murphy-Rose share the signs that your complexion is stressed and offer their best advice for chilling it out.
FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo
Medscape· 6 days agoUnlike the low-concentration formulation of adalimumab-adbm, launched July 1, 2023, this high-concentration version has not yet been granted an interchangeability designation.
Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update
WTNH-TV New Haven· 6 hours agoImmunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today ...
Q2 2024 EPS Estimates for Amgen Inc. Reduced by Leerink Partnrs (NASDAQ:AMGN)
ETF DAILY NEWS· 2 days agoAmgen Inc. (NASDAQ:AMGN – Free Report) – Stock analysts at Leerink Partnrs reduced their Q2 2024 earnings estimates for Amgen in a research report issued on Friday, May 3rd. Leerink Partnrs ...
722 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by McAdam LLC
ETF DAILY NEWS· 7 days agoMcAdam LLC purchased a new position in Amgen Inc. (NASDAQ:AMGN – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission ...
Dr. Ahmed Z. Obeidat Named Finalist for the 2024 "CMSC Neuroinnovator of the Year"
PRWeb· 2 days agoThe recognition highlights the groundbreaking work and innovative approach sponsored by Cytokind, Inc. in addressing unmet needs in MS treatment. Dr. Obeidat of the Medical ...
Amgen (NASDAQ:AMGN) Shares Down 2.7% on Insider Selling
ETF DAILY NEWS· 2 days agoAmgen Inc. (NASDAQ:AMGN – Get Free Report) shares were down 2.7% on Monday after an insider sold shares in the company. The company traded as low as $301.09 and last traded at $302.91. Specifically ...
